Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
The ONTARGET Investigators
- 10 Apr, 2008
This
PowerPoint Slide Set is a value
added service that requires an individual subscription.
Already a print subscriber? Activate your online access
Not a Subscriber?
Get full access to NEJM Online now with a FREE TRIAL!
Or, purchase full access to this
PowerPoint Slide Set for $10
